What the label states, the lot delivers — net peptide mass, not gross powder weight, purity reported as measured rather than rounded up, and a Certificate of Analysis for every lot.
Net peptide mass, not powder weight; purity as measured, not rounded up; a COA per lot.
Net peptide + purity not rounded up. COA per lot.
FDA PCAC reviews 7 peptides for the 503A bulks list (BPC-157, KPV, TB-500, MOTs-C, Emideltide, Semax, Epitalon). Read our compounder's decision tree. Read our briefing →
FDA PCAC reviews 7 peptides for the 503A bulks list in July. Read →
FDA PCAC: 7 peptides under review. Read →
Catalog category
Epitalon, GHK-Cu, and other anti-aging research peptides supporting telomere, collagen and circadian-rhythm research lines.
14 actives in this category · per-lot documented · pricing on request.
What buyers source Longevity Peptides for, which buyer types order it, and the documentation that ships with each lot.
Sourced for
Buyer fit
Documentation that ships
Procurement note: Copper peptides require chelator-free water and EDTA-free buffers in downstream formulation work.
Longevity Peptides actives
12-mer
Pineal tetrapeptide · telomere research
Redox coenzyme for cellular-energy research
9-mer
Reduced glutathione · master antioxidant tripeptide
49-mer
D-retro-inverso FOXO4 / p53 interaction blocker · senolytic peptide
p53-HDM2-binding · penetratin-fused research peptide
9-mer
Khavinson vascular tripeptide (Lys-Glu-Asp, KED)
12-mer
Khavinson cardiovascular short-peptide bioregulator
12-mer
Khavinson cartilage / connective-tissue bioregulator
12-mer
Khavinson bioregulator tetrapeptide (Ala-Glu-Asp-Leu, AEDL)
15-mer
Khavinson cortical bioregulator tetrapeptide (Ala-Glu-Asp-Pro, AEDP)
9-mer
Khavinson immune / endocrine short-peptide bioregulator
53-mer
Semax/P21-family adamantane-modified nootropic (reference name) · exact molecular specification not independently confirmed
Reference-name product · exact chemical identity not independently confirmed
Cyanocobalamin · methyl-donor / metabolic adjunct
Sold for research and for use as a cosmetic ingredient where the receiving formulator's regulatory framework permits (e.g. EU cosmetic regulation 1223/2009, FDA cosmetic-monograph framework, equivalent regimes). Not a finished dosage form. Cosmetic-finished-product safety responsibility remains with the brand owner.
First response under 24 hours · Catalog · Sample COA · MOQ · Lead time. Our regulatory and sales teams review every inquiry before pricing — license verification on every request.